Niranthin is a selective serotonin reuptake inhibitor (SSRI) utilized primarily in the treatment of major depressive disorder and various mood disorders. By modulating neurotransmitter levels to increase… Read more
Niranthin is a selective serotonin reuptake inhibitor (SSRI) utilized primarily in the treatment of major depressive disorder and various mood disorders. By modulating neurotransmitter levels to increase serotonin availability in the synaptic cleft, this compound effectively addresses clinical depression symptoms. To support the rigorous analytical requirements of pharmaceutical development, this category includes a range of essential Niranthin reference standards, including chiral impurities, specific metabolic intermediates, and stable isotope labelled compounds. These high-purity analytical tools are critical for laboratory professionals conducting impurity profiling, method validation, and ongoing quality control assessments. By providing accurate benchmarks for identifying and quantifying related substances, these compounds facilitate the maintenance of strict regulatory compliance and ensure the consistency, safety, and efficacy of Niranthin formulations throughout the drug development lifecycle.